Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX
When assessing a patient presenting with suspected adverse drug reactions (ADRs), the appropriate steps include:
- Take a detailed history and perform a clinical examination to identify the timing, nature, and pattern of the reaction in relation to drug exposure, considering immediate and non-immediate reactions as described in clinical tables of allergic patterns (e.g., anaphylaxis, urticaria, fixed drug eruptions, DRESS, Stevens–Johnson syndrome) NICE CG183.
- Evaluate the temporal relationship between drug administration and onset of symptoms, noting that reactions occurring during or after drug use and consistent with known drug allergy patterns are more likely to be caused by the drug NICE CG183.
- Consider previous similar reactions to the same drug or drug class, which increases the likelihood of drug allergy NICE CG183.
- Exclude alternative non-drug causes for the symptoms, especially if gastrointestinal symptoms are isolated or if similar symptoms have occurred without drug exposure NICE CG183.
- In cases of suspected anaphylaxis, measure serum mast cell tryptase by taking two blood samples as per anaphylaxis guidelines to support diagnosis NICE CG183.
- Involve a pharmacist with relevant clinical knowledge when making decisions about medicines use or care pathways involving medicines NICE NG5.
- Encourage open, person-centred communication to involve the patient in discussions and decisions about their care, ensuring informed consent and shared decision-making NICE NG5,NICE CG183.
- Report and document the suspected ADR through local and national patient safety incident systems to support learning and prevent harm NICE NG5.